Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment

Becky Myers, Beth Levant, Garth Bissette, Charles Nemeroff

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Neurotensin is an endogenous neuropeptide that produces many CNS effects that are similar to the behavioral and physiological alterations seen after administration of antipsychotic drugs to laboratory animals. As previously reported, sub-chronic (3 week) and acute (single injection) treatment with haloperidol (1 mg/kg), a clinically effective antipsychotic drug increases neurotensin concentrations in the nucleus accumbens and the caudate nucleus. In contrast, a tricyclic antidepressant (desipramine, 10 mg/kg), an anxiolytic (chlordiazepoxide, 25 mg/kg) and a histamine H1 receptor antagonist (diphenhydramine, 20 mg/kg) did not alter neurotensin concentrations in these brain regions after sub-chronic or acute treatment. These data demonstrate pharmacologic specificity to the antipsychotic drug-induced increases in regional brain neurotensin concentrations, and support the hypothesis that these changes may contribute to the clinical efficacy of these drugs.

Original languageEnglish
Pages (from-to)325-328
Number of pages4
JournalBrain Research
Volume575
Issue number2
DOIs
StatePublished - Mar 20 1992
Externally publishedYes

Fingerprint

Neurotensin
Antipsychotic Agents
Pharmacology
Histamine H1 Antagonists
Chlordiazepoxide
Diphenhydramine
Desipramine
Caudate Nucleus
Tricyclic Antidepressive Agents
Anti-Anxiety Agents
Nucleus Accumbens
Brain
Laboratory Animals
Haloperidol
Therapeutics
Neuropeptides
Injections
Pharmaceutical Preparations

Keywords

  • Antidepressant
  • Anxiolytic
  • Chlordiazepoxide
  • Desipramine
  • Diphenhydramine
  • Dopamine
  • Haloperidol

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment. / Myers, Becky; Levant, Beth; Bissette, Garth; Nemeroff, Charles.

In: Brain Research, Vol. 575, No. 2, 20.03.1992, p. 325-328.

Research output: Contribution to journalArticle

@article{425ca3791a9946a3b8ebae5c4dfd1bd1,
title = "Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment",
abstract = "Neurotensin is an endogenous neuropeptide that produces many CNS effects that are similar to the behavioral and physiological alterations seen after administration of antipsychotic drugs to laboratory animals. As previously reported, sub-chronic (3 week) and acute (single injection) treatment with haloperidol (1 mg/kg), a clinically effective antipsychotic drug increases neurotensin concentrations in the nucleus accumbens and the caudate nucleus. In contrast, a tricyclic antidepressant (desipramine, 10 mg/kg), an anxiolytic (chlordiazepoxide, 25 mg/kg) and a histamine H1 receptor antagonist (diphenhydramine, 20 mg/kg) did not alter neurotensin concentrations in these brain regions after sub-chronic or acute treatment. These data demonstrate pharmacologic specificity to the antipsychotic drug-induced increases in regional brain neurotensin concentrations, and support the hypothesis that these changes may contribute to the clinical efficacy of these drugs.",
keywords = "Antidepressant, Anxiolytic, Chlordiazepoxide, Desipramine, Diphenhydramine, Dopamine, Haloperidol",
author = "Becky Myers and Beth Levant and Garth Bissette and Charles Nemeroff",
year = "1992",
month = "3",
day = "20",
doi = "10.1016/0006-8993(92)90098-T",
language = "English",
volume = "575",
pages = "325--328",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment

AU - Myers, Becky

AU - Levant, Beth

AU - Bissette, Garth

AU - Nemeroff, Charles

PY - 1992/3/20

Y1 - 1992/3/20

N2 - Neurotensin is an endogenous neuropeptide that produces many CNS effects that are similar to the behavioral and physiological alterations seen after administration of antipsychotic drugs to laboratory animals. As previously reported, sub-chronic (3 week) and acute (single injection) treatment with haloperidol (1 mg/kg), a clinically effective antipsychotic drug increases neurotensin concentrations in the nucleus accumbens and the caudate nucleus. In contrast, a tricyclic antidepressant (desipramine, 10 mg/kg), an anxiolytic (chlordiazepoxide, 25 mg/kg) and a histamine H1 receptor antagonist (diphenhydramine, 20 mg/kg) did not alter neurotensin concentrations in these brain regions after sub-chronic or acute treatment. These data demonstrate pharmacologic specificity to the antipsychotic drug-induced increases in regional brain neurotensin concentrations, and support the hypothesis that these changes may contribute to the clinical efficacy of these drugs.

AB - Neurotensin is an endogenous neuropeptide that produces many CNS effects that are similar to the behavioral and physiological alterations seen after administration of antipsychotic drugs to laboratory animals. As previously reported, sub-chronic (3 week) and acute (single injection) treatment with haloperidol (1 mg/kg), a clinically effective antipsychotic drug increases neurotensin concentrations in the nucleus accumbens and the caudate nucleus. In contrast, a tricyclic antidepressant (desipramine, 10 mg/kg), an anxiolytic (chlordiazepoxide, 25 mg/kg) and a histamine H1 receptor antagonist (diphenhydramine, 20 mg/kg) did not alter neurotensin concentrations in these brain regions after sub-chronic or acute treatment. These data demonstrate pharmacologic specificity to the antipsychotic drug-induced increases in regional brain neurotensin concentrations, and support the hypothesis that these changes may contribute to the clinical efficacy of these drugs.

KW - Antidepressant

KW - Anxiolytic

KW - Chlordiazepoxide

KW - Desipramine

KW - Diphenhydramine

KW - Dopamine

KW - Haloperidol

UR - http://www.scopus.com/inward/record.url?scp=0026597877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026597877&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(92)90098-T

DO - 10.1016/0006-8993(92)90098-T

M3 - Article

VL - 575

SP - 325

EP - 328

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -